Access tomorrow's treatments today.
Connecting patients and physicians to advanced therapeutic options through clinical research.
Every patient has the right to access the best treatments available.
This is why we bring our trials to patients in their own communities. Our approach ensures that patients have access to cutting edge treatments via clinical research, with the convenience of receiving care from their trusted healthcare providers.
Patients should be at the center of everything.
We are committed to delivering compassionate care that is designed to meet the unique needs of each person. Profound enables patients to change the course of their health journey and regain control of their wellbeing.
Everyone can contribute to a better future.
By participating in clinical trials, patients can make a real difference in the lives of others facing similar health challenges. We are a community of doctors and patients committed to advancing medical science and discovering new treatments to help people live longer, healthier lives.
700+ PHYSICIANS
750,000 PATIENT PANEL
3 U.S. GEOGRAPHIES
Therapeutic Areas
Select a therapeutic area below to explore sites:
CONTACT US
A new day for clinical trials
INTEGRATED SITE OPERATIONS
FAST ACTIVATION
RELIABLE ENROLLMENT
ENHANCED STUDY CONDUCT
Our Leadership Team
Lora Parahovnik
Chief Executive Officer
Gregory Sahagian, MD
Chief Scientific Officer
Marty F. Anderson
Chief Operations Officer
David Lamadrid
Chief Financial Officer
Michael Shipton
Chief Commercial Officer
Peter Kaufman
Associate General Counsel
Nicole Bielakowski
SVP, Central Operations
Sara Schmidt
Head of Quality
Iyassu Berhanu
Co-Founder
Jonathan Feldstein, MD
President, Co-Founder
David M. Glaccum
Co-Founder
Courtney C. Miller
SVP, People
Our Values
Compassion
Honor the patient-physician relationship above all else.
Efficiency
Accountable for outcomes and strive for process perfection.
Progress
Contribute to continued innovation in medicine while improving health outcomes.
Integrity
Hold ourselves to the highest ethical, quality, and scientific standards in every activity.
Latest News
Alzheimer’s disease (AD) is a major global health issue, with over 55 million people affected worldwide. Early detection of AD is challenging, as there is currently no simple molecular test for diagnosing the disease. …
Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a clinical research partnership and the formation of a Clinical Research …
Profound Research, a leading clinical trial site network, today announced the key leadership appointment of Michael Shipton as Chief Commercial Officer, a move aimed at driving innovation and continued growth. Shipton brings extensive experience …
